{"name": "Inbiomotion",
 "permalink": "inbiomotion",
 "crunchbase_url": "http://www.crunchbase.com/company/inbiomotion",
 "homepage_url": "http://inbiomotion.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Jul 04 03:39:40 UTC 2012",
 "updated_at": "Thu May 30 08:09:04 UTC 2013",
 "overview": "\u003Cp\u003EInbiomotion is a Barcelona-based personalized medicine company incorporated in 2010 with the goal of Developing biomarkers predict bone metastasis That to Improve the quality of life of cancer patients. The company is a spin out of the IRB Barcelona and ICREA Research Institutions and was founded by Dr. Roger Gomis.\u003C/p\u003E\n\n\u003Cp\u003EOur Activities are focused on the development of a diagnostic assay based on a selective single gene / protein biomarker That Predicts Those patients at risk of suffering bone-specific metastases from primary tumors. The exquisite selectivity of our lead biomarker Provides the grounds for the development of companion diagnostics - Selecting That Will patients benefit from the preventive use of anti-metastatic bone drugs, and making a step forward in the clinical standard of care using personalized medicine.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       76],
      "assets/images/resized/0024/7927/247927v1-max-150x150.png"],
     [[250,
       128],
      "assets/images/resized/0024/7927/247927v1-max-250x250.png"],
     [[250,
       128],
      "assets/images/resized/0024/7927/247927v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder \u0026 Acting CSO \u0026 Non - Executive Director",
    "person":
     {"first_name": "Roger",
      "last_name": "Gomis",
      "permalink": "roger-gomis",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0026/9090/269090v1-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0026/9090/269090v1-max-250x250.jpg"],
          [[300,
            450],
           "assets/images/resized/0026/9090/269090v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Chairman",
    "person":
     {"first_name": "Joel",
      "last_name": "Jean Mairet",
      "permalink": "joel-jean-mairet",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0026/9034/269034v1-max-150x150.jpg"],
          [[182,
            250],
           "assets/images/resized/0026/9034/269034v1-max-250x250.jpg"],
          [[194,
            266],
           "assets/images/resized/0026/9034/269034v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Non - Executive Director - Independent",
    "person":
     {"first_name": "Jon",
      "last_name": "Askaa",
      "permalink": "jon-askaa",
      "image":
       {"available_sizes":
         [[[150,
            100],
           "assets/images/resized/0026/9061/269061v1-max-150x150.jpg"],
          [[250,
            166],
           "assets/images/resized/0026/9061/269061v1-max-250x250.jpg"],
          [[450,
            300],
           "assets/images/resized/0026/9061/269061v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Non - Executive Director",
    "person":
     {"first_name": "Laia",
      "last_name": "Crespo",
      "permalink": "laia-crespo",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0026/9087/269087v1-max-150x150.jpg"],
          [[182,
            250],
           "assets/images/resized/0026/9087/269087v1-max-250x250.jpg"],
          [[194,
            266],
           "assets/images/resized/0026/9087/269087v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Non - Executive Director - Independent",
    "person":
     {"first_name": "David",
      "last_name": "L. Lacey",
      "permalink": "david-l-lacey",
      "image": null}},
   {"is_past": false,
    "title": "Head, Product Development",
    "person":
     {"first_name": "Juan",
      "last_name": "Carlos Tercero",
      "permalink": "juan-carlos-tercero",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120703e873lf9ec\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120703e873lf9ec%26from%3dalert%26pid%3d32",
    "source_description": "Inbiomotion Picks Up $2.5M for Bone Disease Biomarker ",
    "raised_amount": 2500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 7,
    "funded_day": 3,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Inbiomotion SL",
    "address1": "C/Baldiri Reixac 10",
    "address2": "",
    "zip_code": "08028",
    "city": "Barcelona",
    "state_code": null,
    "country_code": "ESP",
    "latitude": 41.3818538,
    "longitude": 2.1164317}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}